Characteristic | Community studya | Facility study | Treatment cohort studies | |||||
---|---|---|---|---|---|---|---|---|
Level | Baseline (n = 1290) | Endline (n = 3481) | Baseline (n = 1893) | Midline (n = 2049) | Endline (n = 1891) | Depression (n = 64) | Psychosis (n = 51) | Epilepsy (n = 117) |
Age (years), % | ||||||||
 16–30 | 494 (38.2) | 1190 (32.7) | 1035 (54.7) | 678 (35.8) | 180 (9.5) | 18 (28.1) | 26 (51.0) | 83 (70.9) |
 31–49 | 555 (44.2) | 1424 (42.3) | 991 (48.4) | 799 (39.0) | 259 (12.6) | 34 (53.1) | 23 (45.1) | 31 (26.5) |
 ≥ 50 | 240 (17.6) | 867 (25.0) | 862 (45.6) | 732 (38.7) | 297 (15.7) | 12 (18.8) | 2 (3.9) | 3 (2.6) |
Female sex, % | 867 (66.4) | 2668 (74.7) | 1500 (79.2) | 1618 (78.9) | 1541 (81.4) | 48 (75.0) | 23 (45.1) | 56 (47.9) |
Marital status | ||||||||
 No partner |  |  |  |  |  | 24 (37.5) | 36 (70.6) | 103 (88.0) |
 Has a partner |  |  |  |  |  | 40 (62.5) | 15 (29.4) | 14 (12.0) |
Highest educationb, % | ||||||||
 Less than primary | 239 (16.9) | 663 (18.2) | 174 (9.2) | 348 (17.0) | 843 (44.6) | 15 (23.4) | 1 (2.0) | 45 (24.9) |
 Primary | 685 (52.6) | 1960 (55.8) | 1113 (58.8) | 1177 (57.4) | 648 (34.2) | – | – | – |
 Secondary | 322 (26.7) | 759 (23.0) | 485 (25.6) | 473 (23.1) | 362 (19.1) | 36 (56.3) | 21 (41.2) | 115 (63.5) |
 Tertiary | 44 (3.7) | 99 (3.0) | 121 (6.4) | 52 (2.5) | 39 (2.1) | 13 (20.3) | 29 (56.9) | 21 (11.6) |
PHQ-9 score | 3.9 (2.4) | 2.2 (3.5) | 3.0 (2.9) | 3.6 (3.5) | 3.3 (3.3) | 16.3 (4.6) | 9.5 (6.5) | 7.6 (5.6) |
PHQ9 positive, % | 85 (6.7) | 302 (8.6) | 80 (4.2) | 158 (7.7) | 111 (5.9) | 61 (95.3) | 23 (45.1) | 46 (39.3) |
Recent depression, % | 316 (24.9) | 380 (10.7) | 159 (8.4) | Â | 314 (16.6) | Â | Â | Â |
AUDIT score | 0.6 (1.6) | 0.6 (2.7) | 0.6 (1.8) | 0.5 (1.9) | 0.6 (2.5) | Â | Â | Â |
AUDIT positive, % | 25 (2.3) | 63 (1.8) | 23 (1.2) | 38 (1.8) | 48 (2.5) | Â | Â | Â |
Number of seizures in past 30 days (median, IQR) |  |  |  |  |  |  |  | 3 (1–5) |